Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in

Status Active, not recruiting

Clinical Trial Summary

Cervical dystonia is the most common form of focal dystonia in adults (50-82%). It manifests itself by a abnormal attitude of the head, intermittent or permanent, due to involuntary contraction of the cervical muscles which appears or is accentuated on the occasion of voluntary movement and maintenance posture. The distribution of dystonic muscles is specific to each patient explaining the diversity of patterns encountered. The therapeutic management of DC is essentially local and symptomatic. It is based on the realization of injections of neuro botulinum toxin (BoNT) targeting target (dystonic) muscles responsible for involuntary movements or posture abnormal. Identifying the muscles involved is a step prerequisite for therapeutic intervention.The obliquus capitis inferior (OCI) also known as Lower Oblique belongs to the group of suboccipital muscles.It is the only suboccipital muscle that does not attach to the skull. Its unilateral contraction causes ipsilateral rotation of C1 therefore of the head. The length of the transverse process of the atlas gives it considerable rotary efficiency. It is described as the cephalic rotation starter muscle. It would perform the 30 first degrees of rotation. The rotation of the whole column cervical would then be continued by the synergistic action of the muscle contralateral sternocleidomatoid and Spl. ipsilateral. The level of joint complex C1-C2 the amplitude of rotation corresponds to approximately 50% of the total rotation of the cervical spine. In order to better understand the part played by the OCI muscle in the disorganization of posture and cervical movements in the axial plane (plane of rotation) in the rotary DC, the investigators want biomechanically analyze its function in pathological situation. The physiology of this muscle is richly documented in healthy subjects. But does this knowledge apply in DC? Acquisition of imagery by the "Cone Beam" or CBCT system (Cone Beam Computed Tomography) before and 5 weeks after the injection of BoNT, will allow the analysis of the displacement of each vertebrate.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05327985
Study type	Observational
Source	Fondation Ophtalmologique Adolphe de Rothschild
Contact
Status	Active, not recruiting
Phase
Start date	April 8, 2022
Completion date	August 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03617367` - Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)	Phase 3
Not yet recruiting	`NCT04057911` - A Trial of Non-invasive Stimulation in Cervical Dystonia	N/A
Withdrawn	`NCT02180139` - tDCS in Cervical Dystonia	N/A
Completed	`NCT00541905` - Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia	Phase 4
Unknown status	`NCT00418925` - Efficacy of Dronabinol for the Treatment of Cervical Dystonia	Phase 2
Not yet recruiting	`NCT05715138` - Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia	N/A
Completed	`NCT02131467` - Safety and Tolerability of Perampanel in Cervical Dystonia	Phase 1/Phase 2
Completed	`NCT02959645` - Assessment of Brain Activities in Cervical Dystonia
Completed	`NCT03805152` - Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia	Phase 3
Completed	`NCT04949594` - Relief of Pain in Patients With Cervical Dystonia Through the Use of Transcutaneous Electric Nerve Stimulation (TENS)
Recruiting	`NCT01664013` - The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients	Phase 4
Completed	`NCT00447772` - Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia	Phase 3
Completed	`NCT00210431` - Post Marketing Surveillance Study of Dysport
Completed	`NCT05157100` - Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia	Phase 4
Completed	`NCT00257660` - Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia	Phase 3
Completed	`NCT05103202` - Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
Terminated	`NCT00760318` - Keppra for Cervical Dystonia	Phase 2
Completed	`NCT00323765` - Plasticity in Cervical Dystonia	N/A
Completed	`NCT04171258` - Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia	Phase 1
Completed	`NCT04849988` - A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in the Rotatory Form of Cervical Dystonia — STOCI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms